Clinical Trials Directory

Trials / Active Not Recruiting

Active Not RecruitingNCT06358157

The Ladera Large Bore Closure Feasibility Study

Evaluation of the Safety and Performance of the Ladera Medical Suture-Mediated Large Bore Closure (LBC) System

Status
Active Not Recruiting
Phase
N/A
Study type
Interventional
Enrollment
30 (estimated)
Sponsor
Ladera Medical · Industry
Sex
All
Age
21 Years
Healthy volunteers
Not accepted

Summary

This study evaluates the safety and performance of the Ladera Medical suture-mediated large bore closure (LBC) system in gaining post procedure hemostasis in subjects undergoing interventional catheterization procedures using a large-bore procedure sheath.

Detailed description

The Ladera Medical suture mediated large bore closure (LBC) system is a vascular closure device intended for use in catheterization laboratories following percutaneous interventional catheterization procedures that use the retrograde common femoral artery access route for large bore interventional devices. The function of Ladera LBC System is to percutaneously close the puncture in the artery wall (arteriotomy) through which the catheters were inserted for the procedure. The study is being conducted to demonstrate the safety and performance of the LBC System in achieving hemostasis in femoral arterial access sites in subjects undergoing percutaneous interventional catheterization procedures using a large-bore procedure sheath.

Conditions

Interventions

TypeNameDescription
DEVICELadera LBC SystemUse of the Ladera LBC System to close the femoral arteriotomy

Timeline

Start date
2024-10-21
Primary completion
2025-12-01
Completion
2025-12-01
First posted
2024-04-10
Last updated
2025-12-17

Locations

3 sites across 1 country: Australia

Regulatory

Source: ClinicalTrials.gov record NCT06358157. Inclusion in this directory is not an endorsement.